Concord Biotech’s board approved a 1:1 bonus share allotment, effective November 4, 2026 Back
<p>Concord Biotech Limited announced that its Board of Directors approved the allotment of 10,46,16,204 equity shares of Rs 1/- each as fully paid-up bonus equity shares in a 1:1 ratio, effective November 4, 2026, as the record date, increasing the company’s paid-up share capital to Rs 20,92,32,408 divided into 20,92,32,408 fully paid-up equity shares of Rs 1/- each.</p>